A Mild and Efficient Synthesis of Pyrazolo[1,5-a]pyridines Mediated by Triphenylphosphine/Diiodine

Abstract

A synthesis of 2,3-diaryl-substituted pyrazolo[1,5-a]pyridines in moderate to good yields under metal-free and mild conditions is described. The intramolecular cyclization of the oxime substrates is mediated by PPh₃/I₂, which leads directly to pyrazolo[1,5-a]pyridines without the formation of a 2H-azirine intermediate. Various substituents on the aryl rings are compatible with the method.

Key words

pyrazolopyridines - oximes - metal-free synthesis - iodine - triphenylphosphine

Publikationsverlauf

Eingereicht: 28. Oktober 2021

Angenommen nach Revision: 24. November 2021

Accepted Manuscript online:
24. November 2021

Artikel online veröffentlicht:
20. Dezember 2021

• References and Notes


For selected examples, see:
• 1a Shultz MD, Cao X, Chen CH, Cho YS, Davis NR, Eckman J, Fan J, Fekete A, Firestone B, Flynn J, Green J, Growney J, Holmqvist DM, Hsu M, Jansson D, Jiang L, Kwon P, Liu G, Lombardo F, Lu Q, Majumdar D, Meta C, Perez L, Pu M, Ramsey T, Remiszewski S, Skolnik S, Traebert M, Urban L, Uttamsingh V, Wang P, Whitebread S, Whitehead L, Yan-Neale Y, Yao Y.-M, Zhou L, Atadja P. J. Med. Chem. 2011; 54: 4752
• 1b Balkenhohl M, Salgues B, Hirai T, Karaghiosoff K, Knochel P. Org. Lett. 2018; 20: 3114
• 1c Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Middekadi VR, Bogaraju N, Ravella SR, Singh P, Birangal SR, Subramanian R, Palacharla RC, Benade V, Muddana N, Jayarajan P. J. Med. Chem. 2018; 61: 4993
• 1d Möller D, Banerjee A, Uzuneser TC, Skultety M, Huth T, Plouffe B, Hübner H, Alzheimer C, Friedland K, Müller CP, Bouvier M, Gmeiner P. J. Med. Chem. 2017; 60: 2908
• 1e Männel B, Hübner H, Möller D, Gmeiner P. Bioorg. Med. Chem. 2017; 25: 5613
• 1f Yoshida N, Aono M, Tsubuki T, Awano K, Kobayashi T. Tetrahedron: Asymmetry 2003; 14: 529
• 1g Kojima A, Takita S, Sumiya T, Ochiai K, Iwase K, Kishi T, Ohinata A, Yageta Y, Yasue T, Kohno Y. Bioorg. Med. Chem. Lett. 2013; 23: 5311
• 1h Takahashi Y, Hibi S, Hoshino Y, Kikuchi K, Shin K, Murata-Tai K, Fujisawa M, Ino M, Shibata H, Yonaga M. J. Med. Chem. 2012; 55: 5255
• 1i Lu Z, Ott GR, Anand R, Liu R.-Q, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ.-W. Bioorg. Med. Chem. Lett. 2008; 18: 1958
• 1j Johnston KA, Allcock RW, Jiang Z, Collier ID, Blakli H, Rosair GM, Bailey PD, Morgan KM, Kohno Y, Adams DR. Org. Biomol. Chem. 2008; 6: 175
• 2a Burja B, Čimbora-Zovko T, Tomić S, Jelušić T, Kočevar M, Polanc S, Osmak M. Bioorg. Med. Chem. 2010; 18: 2375
• 2b Duan G, Zhang G, Yuan S, Ji R, Zhang L, Ge Y. Spectrochim. Acta, Part A 2019; 219: 173
• 2c Tang J, Wang B, Wu T, Wan J, Tu Z, Njire M, Wan B, Franzblauc SG, Zhang T, Lu X, Ding K. ACS Med. Chem. Lett. 2015; 6: 814
• 2d Zhang P, Lv H, Duan G, Dong J, Ge Y. RSC Adv. 2018; 8: 30732
• 2e Lu X, Tang J, Cui S, Wan B, Franzblauc SG, Zhang T, Zhang X, Ding K. Eur. J. Med. Chem. 2017; 125: 41
• 2f Insuasty B, Ramírez J, Becerra D, Echeverry C, Quiroga J, Abonia R, Robledo SM, Vélez ID, Upegui Y, Muñoz JA, Ospina V, Nogueras M, Cobo J. Eur. J. Med. Chem. 2015; 93: 401
• 2g Rashad AE, Hegab MI, Abdel-Megeid RE, Micky JA, Abdel-Megeid FM. Bioorg. Med. Chem. 2008; 16: 7102
• 3a Umei K, Nishigaya Y, Kondo A, Tatani K, Tanaka N, Kohno Y, Seto S. Bioorg. Med. Chem. 2017; 25: 2635
• 3b O’Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D. ACS Med. Chem. Lett. 2019; 10: 1486
• 3c Nishigaya Y, Umei K, Saito Y, Watanabe H, Kondo T, Kondo A, Kawamura N, Tatani K, Kohno Y, Tanaka N, Seto S. Bioorg. Med. Chem. Lett. 2017; 27: 4044
• 3d Ha H.-H, Kim JS, Kim BM. Bioorg. Med. Chem. Lett. 2008; 18: 653
• 3e Allen SH, Johns BA, Gudmundsson KS, Freeman GA, Boyd FL. Jr, Sexton CH, Selleseth DW, Creech KL, Moniri KR. Bioorg. Med. Chem. 2006; 14: 944
• 3f Li A.-R, Johnson MG, Liu J, Chen X, Du X, Mihalic JT, Deignan J, Gustin DJ, Duquette J, Fu Z, Zhu L, Marcus AP, Bergeron P, McGee LR, Danao J, Lemon B, Carabeo T, Sullivan T, Ma J, Tang L, Tonn G, Collins TL, Medina JC. Bioorg. Med. Chem. Lett. 2008; 18: 688
• 3g Alam M, Beevers RE, Ceska T, Davenport RJ, Dickson KM, Fortunato M, Gowers L, Haughan AF, James LA, Jones MW, Kinsella N, Lowe C, Meissner JW, Nicolas AL, Perry BG, Phillips DJ, Pitt WR, Platt A, Ratcliffe AJ, Sharpe A, Tait LJ. Bioorg. Med. Chem. Lett. 2007; 17: 3463
• 3h Johns BA, Gudmundsson KS, Allen SH. Bioorg. Med. Chem. Lett. 2007; 17: 2858
• 3i Zhou H.-J, Wang J, Yao B, Wong S, Djakovic S, Kumar B, Rice J, Valle E, Soriano F, Menon M.-K, Madriaga A, von Soly SK, Kumar A, Parlati F, Yakes FM, Shawver L, Le Moigne R, Anderson DJ, Rolfe M, Wustrow D. J. Med. Chem. 2015; 58: 9480
• 3j Johns BA, Gudmundsson KS, Turner EM, Allen SH, Samano VA, Ray JA, Freeman GA, Boyd FL. Jr, Sexton CJ, Selleseth DW, Creech KL, Moniri KR. Bioorg. Med. Chem. 2005; 13: 2397
• 4 Löber S, Hübner H, Gmeiner P. Bioorg. Med. Chem. Lett. 1999; 9: 97

For reviews, see:
• 5a Priya DD, Nandhakumar M, Roopan SM. Synth. Commun. 2020; 50: 3535
• 5b Kendall JD. Curr. Org. Chem. 2011; 15: 2481 For recent reports on the synthesis of pyrazolo[1,5a]pyridines, see
• 5c Yan P, Duan G, Ji R, Ge Y. Tetrahedron Lett. 2018; 59: 2426
• 5d Ghozlan SA. S, Abdelmoniem DM, Hassaneen HM, Abdelmoniem AM, Abdelhamid IA. J. Heterocycl. Chem. 2018; 55: 1798
• 5e Meng D, Andre P, Bateman TJ, Berger R, Chen Y.-H, Desai K, Dewnani S, Ellsworth K, Feng D, Geissler WM, Guo L, Hruza A, Jian T, Li H, Metzger J, Parker DL, Reichert P, Sherer EC, Smith CJ, Sonatore LM, Tschirret-Guth R, Wu J, Xu J, Zhang T, Campeau L.-C, Orr R, Poirier M, McCabe-Dunn J, Araki K, Nishimura T, Sakurada I, Hirabayashi T, Wood HB. Bioorg. Med. Chem. Lett. 2015; 25: 5437
• 6a Mousseau JJ, Bull JA, Ladd CL, Fortier A, Roman DS, Charette AB. J. Org. Chem. 2011; 76: 8243
• 6b Patnaik S, Dietz HC, Zheng W, Austin C, Marugan JJ. J. Org. Chem. 2009; 74: 8870
• 6c Supranovich VI, Vorob’ev AY, Borodkin GI, Gatilov VY, Shubin VG. Tetrahedron Lett. 2016; 57: 1093
• 6d Vorob’ev AY, Supranovich VI, Borodkin GI, Shubin VG. Beilstein J. Org. Chem. 2017; 13: 800
• 6e Ducray R, Boutron P, Didelot M, Germain H, Lach F, Lamorlette M, Legriffon A, Maudet M, Ménard M, Pasquet G, Renaud F, Simpson I, Young GL. Tetrahedron Lett. 2010; 51: 4755
• 6f Ding S, Yan Y, Jiao N. Chem. Commun. 2013; 49: 4250
• 6g Mousseau JJ, Fortier A, Charette AB. Org. Lett. 2010; 12: 516
• 6h Ravi C, Samanta S, Mohan D, Reddy N, Adimurthy S. Synthesis 2017; 49: 2513
• 6i Shi F, Wu C, Wang Q, Zhao J, Li P. Synthesis 2012; 44: 3033
• 6j Ling L, Chen J, Song J, Zhang Y, Li X, Song L, Shi F, Li Y, Wu C. Org. Biomol. Chem. 2013; 11: 3894
• 6k Motornov VA, Tabolin AA, Nelyubina YV, Nenajdenko VG, Ioffe SL. Org. Biomol. Chem. 2020; 18: 1436
• 6l Ravi C, Mohan DC, Reddy NN. K, Adimurthy S. RSC Adv. 2015; 5: 42961
• 6m Cao W, Zhang H, Huang Q, He D, Han J, Chen J, He W, Deng H, Shao M. Synthesis 2018; 50: 3731
• 7a Tamura Y, Ikeda M. Adv. Heterocycl. Chem. 1981; 29: 71
• 7b Harju K, Kylnlähti I, Paananen T, Polamo M, Nielsen J, Yli-Kauhaluoma J. J. Comb. Chem. 2006; 8: 344
• 7c Chen Z, Su M, Yu X, Wu J. Org. Biomol. Chem. 2009; 7: 4641
• 7d Yu X, Ye S, Wu J. Adv. Synth. Catal. 2010; 352: 2050
• 7e Chen Z, Wu J. Org. Lett. 2010; 12: 4856
• 8 Hoashi Y, Takai T, Kotani E, Koike T. Tetrahedron Lett. 2013; 54: 2199
• 9 Xie F, Qi Z, Li X. Angew. Chem. Int. Ed. 2013; 52: 11862
• 10 Tang H.-T, Zeng J.-H, Chen J.-J, Zhou Y.-B, Li R.-H, Zhan Z.-P. Org. Chem. Front. 2017; 4: 1513
• 11a Johns BA, Gudmundsson KS, Turner EM, Allen SH, Jung DK, Sexton CJ, Boyd FL, Peel MR. Tetrahedron 2003; 59: 9001
• 11b Gudmundsson KS, Johns BA, Allen SH. Bioorg. Med. Chem. Lett. 2008; 18: 1157
• 11c Gudmundsson KS, Johns BA, Wang Z, Turner EM, Allen SH, Freeman GA, Boyd FL. Jr, Sexton CJ, Selleseth DW, Moniri KR, Creech KL. Bioorg. Med. Chem. 2005; 13: 5346
• 11d Stevens KL, Jung DK. M, Alberti J, Badiang JG, Peckham GE, Veal JM, Cheung M, Harris PA, Chamberlain SD, Peel MR. Org. Lett. 2005; 7: 4753
• 12 6-Methyl-2,3-diphenylpyrazolo[1,5-a]pyridine (2c); Typical ProcedureA mixture of oxime 1c (60 mg, 0.2 mmol), PPh₃ (79 mg, 0.3 mmol), I₂ (76 mg, 0.3 mmol), imidazole (27 mg, 0.4 mmol), and THF (2.0 mL) was added under air to a high-pressure tube. The tube was sealed and the mixture was stirred at 30 °C for 40 min, then cooled to R.T., and filtered through a pad of silica gel that was subsequently washed with 1:1 EtOAc–PE (100 mL). The solvents were removed under reduced pressure, and the residue was purified by chromatography [silica gel, EtOAc–PE (1:20)] to give a white solid; yield: 29 mg (52%); mp 110.1 °C.¹H NMR (500 MHz, CDCl₃): δ = 8.31 (s, 1 H), 7.62–7.57 (m, 2 H), 7.48 (d, J = 9.0 Hz, 1 H), 7.41–7.34 (m, 4 H), 7.32 (d, J = 6.1 Hz, 4 H), 6.98 (d, J = 9.1 Hz, 1 H), 2.36 (s, 3 H). ¹³C NMR (126 MHz, CDCl₃): δ = 150.3, 138.3, 133.4, 133.4, 129.9, 128.9, 128.7, 128.4, 128.0, 126.9, 126.5, 126.3, 122.1, 116.6, 109.9, 18.2. HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₀H₁₆N₂: 285.1392; found: 285.1388.
• 13a Appel R. Angew. Chem. Int. Ed. 1975; 14: 801
• 13b Desmaris L, Percina N, Cottier L, Sinou D. Tetrahedron Lett. 2003; 44: 7589
• 13c Baughman TW, Sworen JC, Wagener KB. Tetrahedron 2004; 60: 10943
• 13d Årstad E, Barrett AG. M, Hopkins BT, Köbberling J. Org. Lett. 2002; 4: 1975